VNDA Vanda Pharmaceuticals
- 4.680
- -0.090-1.89%
- 4.650
- -0.030-0.64%
Vanda Pharmaceuticals News
Vanda Pharmaceuticals | ARS/A: Others
Vanda Pharmaceuticals | ARS: Annual Report to Security Holders
Vanda Pharmaceuticals | DEF 14A: Definitive information statements
Vanda Pharmaceuticals | 8-A12B: Registration of a class of securities on a national securities exchange
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Williams Timothy
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Polymeropoulos Mihael Hristos
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wijkstrom Joakim
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birznieks Gunther
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Polymeropoulos Mihael Hristos
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wijkstrom Joakim
Analysis
Price Target
No Data
